Skip to main content
SpringerLink
Log in

Diagnostic Imaging of Mesothelioma

  • Chapter
  • First Online:
Mesothelioma

  • 512 Accesses

Abstract

Medical imaging is critical to the diagnosis and management of malignant pleural mesothelioma, being linked to diagnosis, staging, clinical management, surgical planning, and surveillance. Chest radiography, computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET) all play distinct roles in the assessment of this specific patient population; invariably, the discovery and initial diagnosis of this disease centers on imaging. Optimizing imaging protocols and the ordering of imaging examinations is important to increase sensitivity and early detection. Starting with plain radiographs, this chapter will trace the strengths and weaknesses of each imaging modality as they pertain to pleural mesothelioma and will lead the reader to make improved choices concerning patient care. Having a thorough appreciation of the role of imaging in this specific population is especially important to optimize patient outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Eibel R, Tuengerthal S, Schoenberg SO. The role of new imaging techniques in diagnosis and staging of malignant pleural mesothelioma. Curr Opin Oncol. 2003;15:131–8.

    Article  Google Scholar 

  2. Aberle DR, Balmes JR. Computed tomography of asbestos-related pulmonary parenchymal and pleural diseases. Clin Chest Med. 1991;12:115–31.

    CAS  PubMed  Google Scholar 

  3. Gefter WB, Epstein DM, Miller WT. Radiographic evaluation of asbestos related chest disorders. Crit Rev Diagn Imaging. 1984;21:133–81.

    CAS  PubMed  Google Scholar 

  4. Wechsler RJ, Rao VM, Steiner RM. The radiology of thoracic malignant mesothelioma. Crit Rev Diagn Imaging. 1984;20:283–310.

    CAS  PubMed  Google Scholar 

  5. Marom EM, Erasmus JJ, Pass HI, Patz EF Jr. The role of imaging in malignant pleural mesothelioma. Semin Oncol. 2002;29:26–35.

    Article  Google Scholar 

  6. Wanebo HJ, Martini N, Melamed MR, Hilaris B, Beattie EJ Jr. Pleural mesothelioma. Cancer. 1976;38:2481–8.

    Article  CAS  Google Scholar 

  7. Corson N, Sensakovic WF, Straus C, Starkey A, Armato SG III. Characterization of mesothelioma and tissues present in contrast-enhanced thoracic CT scans. Med Phys. 2011;38:942–7.

    Article  Google Scholar 

  8. Leung AN, Müller NL, Miller RR. CT in differential diagnosis of diffuse pleural disease. AJR. 1990;154:487–92.

    Article  CAS  Google Scholar 

  9. Metintas M, Ucgun I, Elbek O, et al. Computed tomography features in malignant pleural mesothelioma and other commonly seen pleural diseases. Eur J Radiol. 2002;41:1–9.

    Article  Google Scholar 

  10. Müller NL. Imaging of the pleura. Radiology. 1993;186:298–309.

    Article  Google Scholar 

  11. Yilmaz UM, Utkaner G, Yalniz E, Kumcuoglu Z. Computed tomographic findings of environmental asbestos-related malignant pleural mesothelioma. Respirology. 1998;3:33–8.

    Article  CAS  Google Scholar 

  12. Müller KM, Fischer M. Malignant pleural mesotheliomas: an environmental health risk in southeast Turkey. Respiration. 2000;67:608–9.

    Article  Google Scholar 

  13. Rabinowitz JG, Efremidis SC, Cohen B, et al. A comparative study of mesothelioma and asbestos using computed tomography and conventional chest radiography. Radiology. 1982;144:453–60.

    Article  CAS  Google Scholar 

  14. Ng CS, Munden RF, Libshitz HI. Malignant pleural mesothelioma: the spectrum of manifestations on CT in 70 cases. Clin Radiol. 1999;54:415–21.

    Article  CAS  Google Scholar 

  15. Kawashima A, Libshitz HI. Malignant pleural mesothelioma: CT manifestations in 50 cases. AJR Am J Roentgenol. 1990;155:965–9.

    Article  CAS  Google Scholar 

  16. Zhou H, Tamura T, Kusaka Y, Suganuma N, Subhannachart P, Vijitsanguan C, Noisiri W, Hering KG, Akira M, Itoh H, Arakawa H, Ishikawa Y, Kumagai S, Kurumatani N. Development of a guideline on reading CT images of malignant pleural mesothelioma and selection of the reference CT films. Eur J Radiol. 2012;81:4203–10.

    Article  Google Scholar 

  17. Roberts HC, Patsios DA, Paul NS, DePerrot M, Teel W, Bayanati H, Shepherd F, Johnston MR. Screening for malignant pleural mesothelioma and lung cancer in individuals with a history of asbestos exposure. J Thorac Oncol. 2009;4:620–8.

    Article  Google Scholar 

  18. Fasola G, Belvedere O, Aita M, Zanin T, Follador A, Cassetti P, Meduri S, De Pangher V, Pignata G, Rosolen V, Barbone F, Grossi F. Low-dose computed tomography screening for lung cancer and pleural mesothelioma in an asbestos-exposed population: baseline results of a prospective, nonrandomized feasibility trial—an Alpe-adria Thoracic Oncology Multidisciplinary Group Study (ATOM 002). Oncologist. 2007;12:1215–24.

    Article  Google Scholar 

  19. Gudmundsson E, Labby Z, Straus CM, Sensakovic WF, Li F, Rose B, Cunliffe A, Kindler HL, Armato SG III. Dynamic contrast-enhanced CT for the assessment of tumor response in malignant pleural mesothelioma: a pilot study. Eur Radiol. 2018;29(2):682–8.

    Article  Google Scholar 

  20. Patel AM, Berger I, Wileyto EP, Khalid U, Torigian DA, Nachiappan AC, Barbosa EM Jr, Gefter WB, Galperin-Aizenberg M, Gupta NK, Simone CB 2nd, Haas AR, Alley EW, Singhal S, Cengel KA, Katz SI. The value of delayed phase enhanced imaging in malignant pleural mesothelioma. J Thorac Dis. 2017;9:2344–9.

    Article  Google Scholar 

  21. Knuuttila A, Halme M, Kivisaari L, Kivisaari A, Salo J, Mattson K. The clinical importance of magnetic resonance imaging versus computed tomography in malignant pleural mesothelioma. Lung Cancer. 1998;22:215–25.

    Article  CAS  Google Scholar 

  22. Tsim S, Humphreys CA, Cowell GW, Stobo DB, Noble C, Woodward R, Kelly CA, Alexander L, Foster JE, Dick C, Blyth KG. Early contrast enhancement: a novel magnetic resonance imaging biomarker of pleural malignancy. Lung Cancer. 2018;118:48–56.

    Article  Google Scholar 

  23. Bonomo L, Feragalli B, Sacco R, Merlino B, Storto ML. Malignant pleural disease. Eur J Radiol. 2000;34:98–118.

    Article  CAS  Google Scholar 

  24. Lorigan JG, Libshitz HI. MR imaging of malignant pleural mesothelioma. J Comput Assist Tomogr. 1989;13:617–20.

    Article  CAS  Google Scholar 

  25. Kinoshita T, Ishii K, Miyasato S. Localized pleural mesothelioma: CT and MR findings. Magn Reson Imaging. 1997;15:377–9.

    Article  CAS  Google Scholar 

  26. Knuuttila A, Kivisaari L, Kivisaari A, Palomäki M, Tervahartiala P, Mattson K. Evaluation of pleural disease using MR and CT. Acta Radiol. 2001;42:502–7.

    CAS  PubMed  Google Scholar 

  27. Coolen J, De Keyzer F, Nafteux P, De Wever W, Dooms C, Vansteenkiste J, Derweduwen A, Roebben I, Verbeken E, De Leyn P, Van Raemdonck D, Nackaerts K, Dymarkowski S, Verschakelen J. Malignant pleural mesothelioma: visual assessment by using pleural pointillism at diffusion-weighted MR imaging. Radiology. 2015;274:576–84.

    Article  Google Scholar 

  28. Gill RR, Umeoka S, Mamata H, Tilleman TR, Stanwell P, Woodhams R, Padera RF, Sugarbaker DJ, Hatabu H. Diffusion-weighted MRI of malignant pleural mesothelioma: preliminary assessment of apparent diffusion coefficient in histologic subtypes. AJR Am J Roentgenol. 2010;195:W125–30.

    Article  Google Scholar 

  29. Bénard F, Sterman D, Smith RJ, Kaiser LR, Albelda SM, Alavi A. Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography. Chest. 1998;114:713–22.

    Article  Google Scholar 

  30. Flores RM, Akhurst T, Gonen M, Larson SM, Rusch VW. Positron emission tomography defines metastatic disease but not locoregional disease in patients with malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 2003;126:11–6.

    Article  Google Scholar 

  31. Nowak AK, Francis RJ, Phillips MJ, Millward MJ, van der Schaaf AA, Boucek J, Musk AW, McCoy MJ, Segal A, Robins P, Byrne MJ. A novel prognostic model for malignant mesothelioma incorporating quantitative FDG-PET imaging with clinical parameters. Clin Cancer Res. 2010;16:2409–17.

    Article  CAS  Google Scholar 

  32. Francis RJ, Byrne MJ, van der Schaaf AA, et al. Early prediction of response to chemotherapy and survival in malignant pleural mesothelioma using a novel semiautomated 3-dimensional volume-based analysis of serial 18F-FDG PET scans. J Nucl Med. 2007;48:1449–58.

    Article  Google Scholar 

  33. Francis RJ, Segard T, Morandeau L, Lee YC, Millward MJ, Segal A, Nowak AK. Characterization of hypoxia in malignant pleural mesothelioma with FMISO PET-CT. Lung Cancer. 2015;90:55–60.

    Article  Google Scholar 

  34. Tsuji AB, Sogawa C, Sugyo A, Sudo H, Toyohara J, Koizumi M, Abe M, Hino O, Harada YN, Furukawa T, Suzuki K, Saga T. Comparison of conventional and novel PET tracers for imaging mesothelioma in nude mice with subcutaneous and intrapleural xenografts. Nucl Med Biol. 2009;36:379–88.

    Article  CAS  Google Scholar 

  35. Cheng L, Tunariu N, Collins DJ, Blackledge MD, Riddell AM, Leach MO, Popat S, Koh DM. Response evaluation in mesothelioma: beyond RECIST. Lung Cancer. 2015;90:433–41.

    Article  Google Scholar 

  36. Miller AB, Hogestraeten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer. 1981;47:207–14.

    Article  CAS  Google Scholar 

  37. James K, Eisenhauer E, Christian M, et al. Measuring response in solid tumors: unidimensional versus bidimensional measurement. J Natl Cancer Inst. 1999;91:523–8.

    Article  CAS  Google Scholar 

  38. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst. 2000;92:205–16.

    Article  CAS  Google Scholar 

  39. Monetti F, Casanova S, Grasso A, Cafferata MA, Ardizzoni A, Neumaier CE. Inadequacy of the new Response Evaluation Criteria in Solid Tumors (RECIST) in patients with malignant pleural mesothelioma: report of four cases. Lung Cancer. 2004;43:71–4.

    Article  CAS  Google Scholar 

  40. van Klaveren RJ, Aerts JGJV, de Bruin H, Giaccone G, Manegold C, van Meerbeeck JP. Inadequacy of the RECIST criteria for response evaluation in patients with malignant pleural mesothelioma. Lung Cancer. 2004;43:63–9.

    Article  Google Scholar 

  41. Byrne MJ, Nowak AK. Modified RECIST criteria for assessment of response in malignant pleural mesothelioma. Ann Oncol. 2004;15:257–60.

    Article  CAS  Google Scholar 

  42. Armato SG III, Oxnard GR, MacMahon H, et al. Measurement of mesothelioma on thoracic CT scans: a comparison of manual and computer-assisted techniques. Med Phys. 2004;35:1105–15.

    Article  Google Scholar 

  43. Armato SG III, Nowak AK. Revised modified RECIST criteria for assessment of response in malignant pleural mesothelioma (version 1.1). J Thorac Oncol. 2018;13:1012–21.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, The University of Chicago, Chicago, IL, USA

    Christopher M. Straus & Samuel G. Armato III

Authors
  1. Christopher M. Straus
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Samuel G. Armato III
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Samuel G. Armato III .

Editor information

Editors and Affiliations

  1. Department of Medical Oncology, Humanitas Gavazzeni Hospital, Bergamo, Italy

    Giovanni Luca Ceresoli

  2. Scientific Direction, Humanitas Gavazzeni Hospital, Bergamo, Italy

    Emilio Bombardieri

  3. Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy

    Maurizio D'Incalci

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Straus, C.M., Armato, S.G. (2019). Diagnostic Imaging of Mesothelioma. In: Ceresoli, G., Bombardieri, E., D'Incalci, M. (eds) Mesothelioma. Springer, Cham. https://doi.org/10.1007/978-3-030-16884-1_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-16884-1_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-16883-4

  • Online ISBN: 978-3-030-16884-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation